Gene_set	Pathway	Overlap	P-value	Adjusted P-value	Odds Ratio	Combined Score	Genes
KEGG_2021_Human	Hematopoietic cell lineage	4/99	4.2131304291399016e-06	0.00017273834759473595	55.95087719298245	-138.0145897139532	CD55;CD59;FCGR1A;GYPA
KEGG_2021_Human	Phagosome	4/152	2.3172889593808534e-05	0.00047504423667307495	35.67567567567568	-94.73234202435842	C3;FCGR1A;FCGR3A;HLA-A
KEGG_2021_Human	Leishmaniasis	3/77	9.524734696085732e-05	0.0013017137417983835	46.2972972972973	-87.57744084010389	C3;FCGR1A;FCGR3A
KEGG_2021_Human	Complement and coagulation cascades	3/85	0.00012793645194335274	0.0013113486324193655	41.73867595818815	-80.46318508481777	C3;CD55;CD59
KEGG_2021_Human	Staphylococcus aureus infection	3/95	0.0001781206903514478	0.001460589660881872	37.15527950310559	-73.03297766135067	C3;FCGR1A;FCGR3A
KEGG_2021_Human	Systemic lupus erythematosus	3/135	0.0005026926261733311	0.003435066278851096	25.766233766233768	-53.1096007884418	C3;FCGR1A;FCGR3A
KEGG_2021_Human	Tuberculosis	3/180	0.0011634285381276748	0.006814367151890666	19.106537530266344	-40.222430877266724	C3;FCGR1A;FCGR3A
KEGG_2021_Human	Neutrophil extracellular trap formation	3/189	0.0013399484035926713	0.0068672355684124406	18.161290322580644	-38.30003183551744	C3;FCGR1A;FCGR3A
KEGG_2021_Human	Viral myocarditis	2/60	0.0023497251222600107	0.010704303334740048	34.525862068965516	-42.95708800176444	CD55;HLA-A
KEGG_2021_Human	Fc gamma R-mediated phagocytosis	2/97	0.006031622120792857	0.024729650695250713	20.981578947368423	-27.909669646620806	FCGR1A;FCGR3A
KEGG_2021_Human	Osteoclast differentiation	2/127	0.010161324318032567	0.0368505939530367	15.886	-21.510038502238015	FCGR1A;FCGR3A
KEGG_2021_Human	Natural killer cell mediated cytotoxicity	2/131	0.010785539693571716	0.0368505939530367	15.385658914728682	-20.853034219946885	FCGR3A;HLA-A
KEGG_2021_Human	Cell adhesion molecules	2/148	0.0136245920729854	0.0429698673071078	13.565068493150685	-18.413416454449223	CD58;HLA-A
KEGG_2021_Human	Viral carcinogenesis	2/203	0.024762333575826773	0.0634534797880561	9.784825870646767	-13.073912909097736	C3;HLA-A
KEGG_2021_Human	Kaposi sarcoma-associated herpesvirus infection	2/193	0.02252556995474682	0.0634534797880561	10.31020942408377	-13.840129933766221	C3;HLA-A
KEGG_2021_Human	Epstein-Barr virus infection	2/202	0.024534595572492535	0.0634534797880561	9.835	-13.147442958027579	CD58;HLA-A
KEGG_2021_Human	Glycosylphosphatidylinositol (GPI)-anchor biosynthesis	1/26	0.03174141642153645	0.07655282784017615	35.74666666666667	-18.6524135039421	PIGA
KEGG_2021_Human	Nicotinate and nicotinamide metabolism	1/35	0.0425156978752584	0.09684131182697746	26.254901960784313	-14.553318652418731	BST1
KEGG_2021_Human	Allograft rejection	1/38	0.046083072411820386	0.09944241941498083	24.117117117117118	-13.560364723090352	HLA-A
KEGG_2021_Human	Graft-versus-host disease	1/42	0.05082096328161841	0.10152795221046387	21.75338753387534	-12.4264883862275	HLA-A
KEGG_2021_Human	Type I diabetes mellitus	1/43	0.052002121863896134	0.10152795221046387	21.232804232804234	-12.171283962486152	HLA-A
KEGG_2021_Human	Malaria	1/50	0.060233261208856796	0.11225289588923311	18.183673469387756	-10.63265628196324	GYPA
KEGG_2021_Human	Autoimmune thyroid disease	1/53	0.06374115884515756	0.11362554402832434	17.128205128205128	-10.081098986019231	HLA-A
KEGG_2021_Human	Legionellosis	1/57	0.06840002327828267	0.11685003976706623	15.896825396825397	-9.424000900813787	C3
KEGG_2021_Human	Acute myeloid leukemia	1/67	0.07995603885498047	0.13112790372216798	13.47138047138047	-8.082458738692866	FCGR1A
KEGG_2021_Human	Pertussis	1/76	0.09024597396088518	0.140491073337171	11.841481481481482	-7.141387005986298	C3
KEGG_2021_Human	Antigen processing and presentation	1/78	0.09251851170984433	0.140491073337171	11.531024531024531	-6.958150954500108	HLA-A
KEGG_2021_Human	Salivary secretion	1/93	0.1094003568916107	0.16019337973414424	9.632850241545894	-5.8073541800756905	BST1
KEGG_2021_Human	Herpes simplex virus 1 infection	2/498	0.12295964829332588	0.16262405096859228	3.816532258064516	-3.814605004177811	C3;HLA-A
KEGG_2021_Human	Pancreatic secretion	1/102	0.11939326812281527	0.16262405096859228	8.764576457645765	-5.262086311101535	BST1
KEGG_2021_Human	Chagas disease	1/102	0.11939326812281527	0.16262405096859228	8.764576457645765	-5.262086311101535	C3
KEGG_2021_Human	Cellular senescence	1/156	0.17726075583432344	0.2271153434127269	5.672401433691756	-3.209640069203435	HLA-A
KEGG_2021_Human	Transcriptional misregulation in cancer	1/192	0.21391358807496763	0.2657714276082931	4.5823152995927865	-2.441961042053517	FCGR1A
KEGG_2021_Human	Coronavirus disease	1/232	0.25290994493508406	0.2802515606037418	3.7696007696007694	-1.8563524399324505	C3
KEGG_2021_Human	Human immunodeficiency virus 1 infection	1/212	0.23363497492364255	0.2802515606037418	4.137440758293839	-2.12256354972075	HLA-A
KEGG_2021_Human	Human cytomegalovirus infection	1/225	0.24621391857748554	0.2802515606037418	3.890873015873016	-1.9442968935376908	HLA-A
KEGG_2021_Human	Human T-cell leukemia virus 1 infection	1/219	0.24043153000367978	0.2802515606037418	4.001019367991845	-2.0240281738454993	HLA-A
KEGG_2021_Human	Shigellosis	1/246	0.26614163456811335	0.2856832725790501	3.547845804988662	-1.6951894904190261	C3
KEGG_2021_Human	Endocytosis	1/252	0.27174750318495006	0.2856832725790501	3.4603806994245243	-1.6315316807371463	HLA-A
KEGG_2021_Human	Neuroactive ligand-receptor interaction	1/341	0.3504975915199974	0.3504975915199974	2.5254901960784313	-0.9533164047874388	C3
KEGG_2021_Human	Human papillomavirus infection	1/331	0.3420488957114324	0.3504975915199974	2.6053872053872054	-1.0106876845884132	HLA-A
